Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.4421
-0.0249 (-5.33%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Lyell Immunopharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lyell Immunopharma stock have an average target of 1.00, which predicts an increase of 126.19% from the current stock price of 0.44.
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for Lyell Immunopharma stock from 2 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +126.19% | Apr 16, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +126.19% | Mar 13, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +126.19% | Nov 12, 2024 |
B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $6 → $1 | Strong Buy → Sell | Downgrades | $6 → $1 | +126.19% | Oct 30, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +126.19% | Oct 28, 2024 |
Financial Forecast
Revenue This Year
n/a
from 61.00K
Revenue Next Year
n/a
EPS This Year
-0.75
from -1.31
EPS Next Year
-0.74
from -0.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.74 | -0.60 | -0.42 |
Avg | -0.75 | -0.74 | -0.65 |
Low | -0.79 | -0.84 | -0.86 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.